Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Malaria × Lymphoid × Clear all

Phase

Phase 1 2 Phase 4 1 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 309 Lymphoma, Non-Hodgkin 259 Precursor Cell Lymphoblastic Leukemia-Lymphoma 221 Leukemia, Lymphocytic, Chronic, B-Cell 208 Lymphoma, Large B-Cell, Diffuse 187 Leukemia 174 Lymphoma, Follicular 158 Lymphoma, Mantle-Cell 146 Hodgkin Disease 126 Recurrence 120 Leukemia, Myeloid, Acute 117 Lymphoma, B-Cell 114 Burkitt Lymphoma 108 Lymphoma, B-Cell, Marginal Zone 82 Multiple Myeloma 79 Myelodysplastic Syndromes 73 Waldenstrom Macroglobulinemia 54 Neoplasms 49 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 47 Lymphoma, T-Cell, Peripheral 46 Lymphoma, T-Cell, Cutaneous 46 Hematologic Neoplasms 43 Lymphoma, Large-Cell, Anaplastic 38 Lymphoma, Large-Cell, Immunoblastic 36 Mycosis Fungoides 34 Lymphoma, T-Cell 34 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 34 Leukemia, B-Cell 32 Sezary Syndrome 27 Neoplasms, Plasma Cell 27

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00341250 2017-07-02

Malaria Vaccine in Children in Mali

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed

Burkitt Lymphoma, Malaria

Data powered by HemOnc (CC BY 4.0) Colophon ⚡